A detailed history of Emerald Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Emerald Advisors, LLC holds 3,147 shares of AMGN stock, worth $1.06 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,147
Previous 3,331 5.52%
Holding current value
$1.06 Million
Previous $947,000 3.8%
% of portfolio
0.15%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $48,346 - $58,753
-184 Reduced 5.52%
3,147 $983,000
Q1 2024

Apr 25, 2024

BUY
$268.87 - $324.56 $9,948 - $12,008
37 Added 1.12%
3,331 $947,000
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $18,666 - $21,057
73 Added 2.27%
3,294 $948,000
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $72,154 - $89,581
330 Added 11.41%
3,221 $865,000
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $52,924 - $62,582
247 Added 9.34%
2,891 $641,000
Q1 2023

Apr 07, 2023

SELL
$225.79 - $275.2 $21,450 - $26,144
-95 Reduced 3.47%
2,644 $639,000
Q4 2022

Jan 20, 2023

SELL
$229.03 - $291.01 $41,454 - $52,672
-181 Reduced 6.2%
2,739 $0
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $20,874 - $23,542
93 Added 3.29%
2,920 $658,000
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $18,687 - $20,795
-81 Reduced 2.79%
2,827 $688,000
Q1 2022

Apr 26, 2022

BUY
$219.27 - $242.57 $26,531 - $29,350
121 Added 4.34%
2,908 $703,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $150,552 - $172,293
757 Added 37.29%
2,787 $627,000
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $27,595 - $32,331
130 Added 6.84%
2,030 $432,000
Q2 2021

Aug 02, 2021

BUY
$233.58 - $259.14 $39,241 - $43,535
168 Added 9.7%
1,900 $463,000
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $6,657 - $7,758
30 Added 1.76%
1,732 $431,000
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $368,278 - $438,554
1,702 New
1,702 $391,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $180B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Emerald Advisors, LLC Portfolio

Follow Emerald Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.